Patient Safety

Our Primary Concern

RLS is committed to maintaining high standards in the industry, from agent compounding to customer delivery. Our continuous focus on safety has created an innovative WBC labeling process that supports patient blood integrity.

Innovative leukocyte-locking system. RLS maintains high-quality standards by routinely upgrading operational procedures to provide the best available practices. One of our key services is the procedure of radiolabeling autologous leukocytes (WBC labeling process). We have also implemented a uniquely keyed locking system to ensure limited access during the entire labeling process.

Innovative leukocyte-locking system

Our robust chain of custody and unique secure lock system includes multiple steps of verification throughout the pickup and delivery of the WBC specimen. This means that the specific patient-labeled sample is returned for administration to the patient identified on the label.

Ensures sample integrity through the entire process from sample collection to patient injection
Secure lock system ensures only you can access your patient’s sample
Chain of custody maintained throughout the transport and labeling process

Setting the standard to provide excellence

RLS is the only nationwide radiopharmacy network to have achieved The Joint Commission Gold Seal of Approval
RLS only compounds and dispenses FDA-approved radiopharmaceutical products, a key step in ensuring patient safety
Highly trained staff – RLS has a team of experienced Nuclear Pharmacists and Radiation Safety Officers available to support you and your staff
Fully equipped and aligned to USP<825> standards
Enhanced procedures for COVID-19 – we have enhanced our procedures to keep your patients, staff and our team safe while continuing to provide high quality products and services